AFP and neoplasm: [9,10] Several risk factors have been identified for a poor prognosis in patients undergoing TACE, including the alpha-fetoprotein level, tumor number and size, tumor thrombus, number of lobar involvements, Model of End-Stage Liver Disease score, and tumor imaging features (such as irregular margin and internal arteries).